BIIB vs FIP · P/E 21, rev $9.89B vs rev $502.5M
Biogen Inc (BIIB) versus FTAI Infrastructure Inc. (FIP) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
FTAI Infrastructure Inc. (FIP) is a conglomerates company listed on NASDAQ.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported FIP revenue for 2025-12-31 was $502.5M. Net income was -$152.1M. Revenue was up 51.6% from 2024-12-31 to 2025-12-31. FIP currently screens at market cap $560.1M.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. FIP currently screens at market cap $560.1M.
Not investment advice. Open the BIIB and FIP stock pages for the full models.
Not investment advice.